Molecular and phylogenetic analysis of haemagglutinin and neuraminidase sequences from recent human influenza type a (H3N2) viral isolates in Southern Greece

Archives of Virology

Volumn 146, Issue 10, 2001, Pages 1899-1918

  Plakokefalos, E T ^a   Markoulatos, P ^a   Spyrou, N ^a   Bei, T A ^b   Vamvakopoulos, N C ^b  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DISEASE CONTROL; GENE SEQUENCE; GENETIC DIFFERENCE; GENETIC RELATIONSHIP; GREECE; HEMAGGLUTININ; HUMAN INFLUENZA A VIRUS; MOLECULAR ANALYSIS; PHYLOGENETIC ANALYSIS; RECOMBINANT GENE; SIALIDASE; VALINE;

AMINO ACID SEQUENCE; GREECE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H3N2 SUBTYPE; MOLECULAR SEQUENCE DATA; NEURAMINIDASE; PHYLOGENY;

EID: 0034753058     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050170041     Document Type: Article

References (37)

1. Orthomyxoviridae: The viruses and their replication
2. Virus taxonomy
3. Influenza
4. Efficacy and safety of the neuraminidase inhibitor Zanamivir in the treatment of Influenzavirus infections
5. Role of the hemagglutinin cleavage for the pathogenicity of influenza virus
6. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid
7. Genetic variation in neuraminidase genes of influenza A (H3N2) viruses
8. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation
9. Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution
10. Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site
11. Site-directed mutation of the active site of influenza neuraminidase and implications for the catalytic mechanism
12. Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: Multiple evolutionary pathways and sequential amino acid changes at key antigenic sites
13. Characterization of a novel influenza hemagglutinin, H15: Criteria for determination of influenza A subtypes
14. Genetic and antigenic variation in the haemagglutinin of recently circulating human A (H3N2) viruses in the United Kingdom
15. The Neighbor-joining method: A new method for reconstructing phylogenetic trees
16. Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus
17. Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells
18. Antigenic and structural characterization of multiple sub- populations of H3N2 influenza virus from an individual
19. Host-cell mediated variation in H3N2 viruses
20. Influence of host cell-mediated variation on the international surveillance of influenza A (H3N2) viruses
21. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity
22. The role of influenza virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction
23. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates
24. CLUSTAL V: Improved software for multiple sequence alignment
25. Phylogenetic analysis of the entire genome of influenza A (H3N2) viruses from Japan: Evidence for genetic reassortment of the six internal genes
26. Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses
27. Structure of the catalytic and antigenic site in influenza virus neuraminidase
28. Origin and evolutionary characteristics of antigenic reassortant influenza A (H1N2) viruses isolated from man in China
29. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species
30. Evolution and ecology of influenza A viruses
31. Long term trends in the evolution of H(3) HA1 human influenza type A
32. A comparative study of immunocapture ELISA and RT-PCR for screening clinical samples from Southern Greece for human influenza virus types A and B
33. Evolution of the HA1 domain of human influenza A (H1N1) virus: Loss of glycosylation sites and occurrence of herald and conserved strains
34. Recommended composition of influenza vaccines for use in the 1996-1997 season
35. Recommended composition of influenza vaccines for use in the 1997-1998 season
36. Recommended composition of influenza vaccines for use in the 1998-1999 season